Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Unscrambling EGS investment in Trump's world
Finance

David Chaplin: Unscrambling EGS investment in Trump's world

The US rush from ESG investments labels is well under way.

Risk is a four-letter word in NZ
Economy

Dileepa Fonseka: Risk is a four-letter word in NZ

NZ was once a global leader. Then it got comfortable.

Dileepa Fonseka 03 Feb 2025
The rise of tech apps and wobbly share prices
Opinion

Simon Robertson: The rise of tech apps and wobbly share prices

Some app stocks are climbers, others not so much. 

Simon Robertson 01 Feb 2025
We need to unlock a 'Go' economy
Economy

Cameron Bagrie: We need to unlock a 'Go' economy

New Zealand is no longer a high-income OECD economy.

Cameron Bagrie 30 Jan 2025